01
Low NADAC$0.039
→
Avg plan cost$0.063
Part D spend $245.8M
2× spread, current vs floor
Drug class profile · refreshed daily from federal data
Serotonin Reuptake Inhibitor
4 molecules in this class, $508.3M combined CY2024 Part D spend across 41.1M claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily
Class summary at a glance.
Every drug in the Serotonin Reuptake Inhibitor class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.
- Molecules in class
- 4tracked in Part D
- CY24 Part D spend
- $508.3Mcombined across class
- Total Rx claims
- 41.1M10.7M unique beneficiaries
- Generic mfrs (active)
- 54across all molecules
Every drug in this class, ranked by Part D spend.
02
Low NADAC$0.029
→
Avg plan cost$0.687
Part D spend $148.8M
24× spread, current vs floor
03
Low NADAC$0.025
→
Avg plan cost$0.046
Part D spend $78.3M
2× spread, current vs floor
04
Low NADAC$0.140
→
Avg plan cost$1.77
Part D spend $35.4M
13× spread, current vs floor